OMDA - Omada Health, Inc. Common Stock

https://www.omadahealth.com

Momentum: Bearish

Recent News

Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - Omada Health ( NASDAQ:OMDA )

Benzinga • 1 month, 4 weeks ago • score: 0.25

SAN FRANCISCO, July 17, 2025 ( GLOBE NEWSWIRE ) -- Omada Health OMDA, the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, 2025, after market close, and host a conference call to review the results at 4:30 pm ...

Neutral

This Rollins Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Fossil Group ( NASDAQ:FOSL ) , New Fortress Energy ( NASDAQ:NFE )

Benzinga • 2 months, 1 week ago • score: -0.02

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Compass Point analyst Giuliano Bologna initiated coverage on New Fortress Energy Inc.

Bearish

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Gold Royalty ( AMEX:GROY ) , IonQ ( NYSE:IONQ )

Benzinga • 2 months, 4 weeks ago • score: -0.54

U.S. stock futures were higher this morning, with the Dow futures gaining more than 150 points on Monday. Shares of Sarepta Therapeutics, Inc. SRPT fell sharply in today's pre-market trading after the company suspended ELEVIDYS shipments and paused ENVISION trial after second fatal liver failure ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Omada Health, Inc. provides a range of virtual care programs in the United States. The company is headquartered in San Francisco, California.

52W High

$28.40

52W Low

$14.14

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

As of 2025-03-31 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

7.38

P/S (TTM) (<3 favorable)

5.32

P/B (<3 favorable)

N/A

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

12.14%

Institutions (25–75% balanced)

42.55%

Shares Outstanding

55,744,000

Float

5,438,400

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

As of 2025-03-31 (Overview)

Revenue (TTM)

189,668,000

Gross Profit (TTM)

117,429,000

EPS (TTM)

-0.79

Profit Margin (>10% good)

-0.20%

Operating Margin (TTM) (higher better)

-0.15%

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.57

Momentum

Bearish momentum

Value

0.8768

1.0472

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025